Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308A, and risk of non-Hodgkin lymphoma

Leukemia. 2010 May;24(5):1055-8. doi: 10.1038/leu.2010.17. Epub 2010 Feb 11.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, N.I.H., Intramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Case-Control Studies
  • DNA / analysis
  • DNA / genetics
  • Genetic Variation / genetics*
  • HLA-A1 Antigen / genetics*
  • HLA-B8 Antigen / genetics*
  • HLA-DR3 Antigen / genetics*
  • Haplotypes / genetics*
  • Humans
  • Lymphoma, Non-Hodgkin / classification
  • Lymphoma, Non-Hodgkin / genetics*
  • Lymphoma, Non-Hodgkin / pathology
  • Prognosis
  • SEER Program
  • Survival Rate
  • Tumor Necrosis Factor-alpha / genetics*

Substances

  • HLA-A1 Antigen
  • HLA-B8 Antigen
  • HLA-DR3 Antigen
  • Tumor Necrosis Factor-alpha
  • DNA